Unique Imaging Findings of Neurologic Phantosmia Following Pfizer-BioNtech COVID-19 Vaccination: A Case Report.

Q2 Medicine

Topics in Magnetic Resonance Imaging Pub Date : 2021-06-01 DOI:10.1097/RMR.0000000000000287

Graham Keir, Naomi I Maria, Claudia F E Kirsch

引用次数: 13

Abstract

Abstract: Olfactory dysfunction related to SARS-CoV-2 infection and COVID-19 disease is now well established in the literature. In December 2020, the FDA approved the Pfizer-BioNTech and Moderna vaccines for use in preventing COVID-19 in the United States. To the best of our knowledge, this is the first report of a phantosmia post-Pfizer COVID-19 vaccination, with positive magnetic resonance imaging radiographic findings in a patient with documented absence of infection by SARS-CoV-2 virus or concomitant sinonasal disease.

查看原文本刊更多论文

辉瑞- biontech COVID-19疫苗接种后神经性幻影的独特影像学发现:一例报告。

摘要:嗅觉功能障碍与SARS-CoV-2感染和COVID-19疾病的关系已在文献中得到证实。2020年12月，FDA批准了辉瑞- biontech和Moderna疫苗在美国用于预防COVID-19。据我们所知，这是首例在辉瑞公司接种COVID-19疫苗后出现幻像的报告，患者的磁共振成像结果为阳性，没有记录的SARS-CoV-2病毒感染或伴随的鼻窦疾病。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Topics in Magnetic Resonance Imaging Medicine-Medicine (all)

CiteScore

5.50

自引率

0.00%

发文量

期刊介绍： Topics in Magnetic Resonance Imaging is a leading information resource for professionals in the MRI community. This publication supplies authoritative, up-to-the-minute coverage of technical advances in this evolving field as well as practical, hands-on guidance from leading experts. Six times a year, TMRI focuses on a single timely topic of interest to radiologists. These topical issues present a variety of perspectives from top radiological authorities to provide an in-depth understanding of how MRI is being used in each area.